Oncolytic Adenoviruses: Strategies for Improved Targeting and Specificity

Praveensingh B Hajeri1, Nikita S Sharma1, Masato Yamamoto1,2,3

  • 1Division of Basic and Translational Research, Department of Surgery, University of Minnesota, MMC 195, 420 Delaware St SE, Minneapolis, MN 55455, USA.

Cancers
|June 13, 2020
PubMed

Insights

Cancer treatments often cause systemic toxicity. Adenoviruses offer targeted gene delivery for cancer therapy. This review explores strategies to enhance oncolytic virus specificity for improved cancer treatment outcomes.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Cancer poses a significant global health challenge.
  • Current cancer treatments frequently result in systemic toxicity due to lack of specificity.
  • Targeted therapies are crucial for improving treatment efficacy and reducing side effects.

Purpose of the Study:

  • To review strategies for enhancing the specificity of oncolytic viruses for cancer cells.
  • To explore the potential of adenoviruses as gene delivery vectors in cancer therapy.
  • To discuss the combination of enhanced oncolytic virotherapy with conventional treatments.

Main Methods:

  • Literature review of existing strategies for oncolytic virus targeting.
  • Analysis of adenovirus-based gene delivery systems.
  • Synthesis of findings on enhancing viral specificity towards cancer cells.

Main Results:

  • Various strategies have been developed and tested to improve oncolytic virus targeting.
  • Adenoviruses demonstrate significant potential as effective gene delivery vectors for cancer.
  • Enhanced specificity can be achieved through multiple approaches.

Conclusions:

  • Targeted oncolytic virotherapy using adenoviruses holds promise for cancer treatment.
  • Combining enhanced viral strategies with conventional therapies may yield superior results.
  • Further research into optimized viral targeting is essential for clinical translation.

Related Concept Videos